Where ginger actually earns its keep is acute and short: a single gram before surgery, a gram a day before chemo, a gram and a half through a rough first trimester, a couple of grams across the first four days of a period. Costs almost nothing, asks almost nothing of the person taking it, and the side-effect column is mostly just "a little heartburn at high doses." The chronic-disease pitches — arthritis cures, blood-sugar transformation — are real but small, and worth honest framing rather than the marketing it usually gets.
The pungent compound in fresh ginger root is called 6-gingerol; when ginger is dried or cooked, some of it converts to a related compound, 6-shogaol. Together they do two things at once that almost no other over-the-counter substance pulls off. They sit on the same receptor that hospital antiemetics like ondansetron target — the 5-HT3 receptor — and quiet the signal that tells the brain to vomit Marx et al. 2013. And in the gut itself, they speed the stomach up: in a clean crossover study of healthy adults, 1.2 g of ginger powder cut the time the stomach took to empty in half-time terms from 16 minutes to 12, and started visible contractions within half an hour Wu et al. 2008.
That combination — calming the vomit reflex from above while pushing food through from below — is why ginger works for the nausea that comes from a stalled stomach (pregnancy, post-op, gastroparesis) without the foggy, constipating side-effects of the prescription antiemetics.
The pain story runs through a different lever. Gingerols block the same enzyme ibuprofen blocks — COX-2 — which is what produces the chemical signals behind inflammation and menstrual cramps Mashhadi et al. 2013. Same family of effect as an NSAID, smaller in magnitude, with a side-effect column that doesn't include the stomach lining or the kidneys.
Where the evidence actually lives
Ginger has been put through more than a hundred randomised trials Anh et al. 2020. The evidence is not evenly distributed. There's a cluster of indications where it's solid and a cluster where it's modest, and the difference between them is the difference between "carry it on the plane" and "don't bet your arthritis on it."
Nausea — the strong cluster
Before surgery, a single 1 g dose of ginger taken with the pre-op water cut next-day nausea rates by roughly a third compared with placebo, across five trials and 363 patients Chaiyakunapruk et al. 2006. The effect was about what 4 mg of intravenous ondansetron gets you in the same setting. Pre-anaesthesia clinics in some hospitals now mention it.
In pregnancy, the meta-analysis of twelve trials in 1,278 women landed on the same dose range — 1 to 1.5 g a day in divided portions — and found a real reduction in morning sickness, with no signal of harm to miscarriage rates or congenital anomalies Viljoen et al. 2014. The American College of Obstetricians and Gynecologists lists ginger as a first-line non-drug option for nausea and vomiting of pregnancy. For motion sickness, a small lab study using a rotating-drum nausea provocation showed both the symptoms and the stomach-rhythm disturbances of motion sickness improving on 1 g of ginger Lien et al. 2003. The signal repeats across every setting it's been tested in.
Menstrual pain — the other strong one
A meta-analysis of six trials, roughly 500 women, found 750 mg to 2 g a day of ginger powder during the first three or four days of a period reduced cramp pain substantially compared with placebo Daily et al. 2015. Head-to-head against ibuprofen 400 mg and mefenamic acid 250 mg, ginger 250 mg taken four times a day was non-inferior — same pain relief, no NSAID side effects Ozgoli et al. 2009. This is one of the better-evidenced non-prescription options for primary dysmenorrhoea.
Joint pain, sore muscles, blood sugar — the modest cluster
For knee arthritis, five trials in 593 patients found ginger reduced pain and disability, but the effect was small — about a third of what you'd get from an NSAID — and roughly a third of users had mild stomach upset on it Bartels et al. 2015. Honest framing: a useful add-on to exercise and weight management, not a substitute for either.
For the deep muscle soreness that shows up the day after an unusually hard workout, 2 g a day of ginger for eleven days reduced pain twenty-four hours after eccentric exercise by about a quarter in a controlled trial of 74 adults Black et al. 2010. Small effect, but real.
In type-2 diabetes, twelve weeks of 2 g of ginger powder daily dropped fasting blood sugar by about 11% and lowered HbA1c — the three-month blood sugar average — by roughly half a percentage point compared with placebo Khandouzi et al. 2015. Meta-analyses of similar trials land in the same range Anh et al. 2020. That's a real number, but no trial has yet shown this prevents heart attacks or extends life — the chain from biomarker to outcome is not made. And importantly, none of this shows up in people without diabetes. A healthy adult taking ginger for "blood sugar" is buying nothing.
How to actually use it
The number to remember is roughly a gram a day of dried ginger powder. That's about a thumb-sized piece of fresh root, a level half-teaspoon of dried powder, or one standardized capsule. Fresh and dried both work; for the indications below the trials mostly used dried-and-encapsulated, which is the only reliable way to know what dose you're taking.
Onset is roughly half an hour to an hour. The active compounds clear out in a few hours, which is why splitting the day's dose into two or three smaller ones generally works better for the chronic uses than swallowing it all at once.
Fresh and supplemental are both fine, but they're not interchangeable for dose. A slice in a stir-fry is somewhere around 100-300 mg of dried equivalent — well below the trial doses. If you want the trial-level effect, you want the trial-level dose, which usually means a measured capsule.
When not to
If you have reflux, ginger can cut both ways. The pro-stomach-emptying effect helps if your problem is a stomach that's slow to empty, and makes things worse if your problem is acid coming up. Most people figure out which camp they're in within a week of trying it.
Pregnancy through 1.5 g a day has been studied across twelve trials with no signal of harm Viljoen et al. 2014; ACOG endorses it. Higher doses haven't been studied in pregnancy, so stay at or below that line.
What most people get wrong
"Ginger settles the stomach by slowing it down." Backwards. Ginger speeds the stomach up; that's part of why it helps the kind of nausea where food sits there going nowhere Wu et al. 2008. It's also why it can make acid reflux worse — speeding up a stomach that's already pushing acid the wrong direction doesn't help.
"Ginger is anti-inflammatory like ibuprofen." Directionally true — same enzyme target — but the dose-for-dose effect on arthritis pain is about a quarter to a third of an NSAID's Bartels et al. 2015. Helpful as something added on top of physical therapy and weight management; not a substitute for treatment.
"Ginger lowers blood sugar." Only in people who already have type-2 diabetes or whose fasting sugar is already elevated. In healthy adults with normal blood sugar, ginger doesn't move the needle on fasting glucose or HbA1c Anh et al. 2020. A perfectly healthy person taking ginger supplements "for blood sugar" is paying for nothing.
"More is better." The chemotherapy-nausea trial tested 0.5 g, 1 g, and 1.5 g daily — and the 1.5 g arm did worse than the lower doses Ryan et al. 2012. A gram is the dose. Pushing past 2 g doesn't add benefit and starts to add heartburn.
What else does the same job
For pregnancy nausea, vitamin B6 (pyridoxine) has comparable evidence and is often the first thing obstetricians reach for; in the US and Canada it's usually combined with doxylamine into a single pill (Diclegis/Diclectin). Most people try ginger and B6 in some order before stepping up to prescription antiemetics.
For chemotherapy nausea, the 5-HT3 antagonists (ondansetron and similar) and steroid antiemetics remain the first-line drugs. Ginger is an adjunct — added on top to take the edge off, not used instead. For the heavy-hitter chemotherapy regimens, the prescription drugs do the heavy lifting.
For post-operative nausea, ondansetron, dexamethasone, and acupressure at the inside of the wrist (the PC6 point) all have RCT evidence at roughly similar effect sizes to ginger. Most anaesthetists stack two or three of these for high-risk patients.
For period cramps, NSAIDs — ibuprofen, mefenamic acid, naproxen — are first-line. Ginger is a viable substitute for people who can't tolerate NSAIDs (stomach lining issues, asthma triggered by aspirin-class drugs, kidney concerns), and a useful addition for people who can but still aren't fully covered Ozgoli et al. 2009.
For knee arthritis, the things with bigger effect sizes are exercise (by a long way the highest-evidence intervention in the catalogue for OA), losing weight if there's weight to lose, topical NSAIDs, paracetamol, and oral NSAIDs. Ginger goes underneath all of these.
Why "I tried it and it didn't do anything" usually means one of two things
The dose was a tenth of the trial dose. A slice of fresh ginger in a stir-fry or a single tea bag has somewhere around 100-300 mg of dried-ginger equivalent. The trials used 1 to 2 grams. A daily cup of weak tea is a tenth of the trial dose; the trial result doesn't carry over.
The form was wrong for the use. Fresh ginger and candied ginger work fine for acute nausea — you don't need to be precise. For period pain, joint inflammation, or blood sugar, where the trials used standardized powdered extract, fresh root is hard to dose because the active-compound content varies with how the root was grown, stored, and prepared. If you want the trial result, you want a measured capsule. Standardized extracts labelled "4-5% gingerols" are the closest match to what was tested.
And the timing matters more than people expect for the chemotherapy and motion-sickness uses. Ginger taken after the nausea has already started is much weaker than ginger taken a half-hour to a day before the trigger. The plane, the chemo infusion, the boat — load before, not after.
What it costs, where to get it
Fresh ginger root sells per pound in essentially every grocery store on the planet; a year of cooking with it runs under $30. Standardized capsules — the kind the trials used — run roughly $15-25 a month for a daily 1-2 g dose. No prescription, no clinician visit, no monitoring labs. Storage: fresh root keeps about three weeks in the fridge crisper, six months in the freezer (peel and grate it straight from frozen). Candied ginger and crystallised ginger work for nausea on the go but carry meaningful sugar; a couple of pieces is not a substitute for a measured capsule when the use is chronic.
Related
If nausea or stomach trouble brought you here, the related entries worth knowing about are the rest of the small-intervention stack for the same problem: vitamin B6 (the other first-line for pregnancy nausea), PC6 acupressure wristbands (the wrist-point trick with surprisingly real RCT evidence for motion and post-op nausea), and peppermint oil for irritable-bowel cramping. If period pain brought you here, the catalogue's NSAID entries and the heat-application page sit alongside this one. And if joint pain brought you here, the much bigger lever is the exercise category — ginger is at most an add-on to the work the leg is doing.
Substance + claimed effects
Ginger is the rhizome of Zingiber officinale, used as a culinary spice across most cuisines and as a concentrated extract in capsule, powder, and tea form. Its pharmacologically active fraction is the gingerols — chiefly 6-gingerol, the dominant pungent compound in fresh rhizome — and their dehydrated cousins, the shogaols (chiefly 6-shogaol), which form when ginger is dried or heated Mashhadi et al. 2013. This entry covers ginger as taken regularly by adults, whether in food or as a 0.5–2 g/day powdered extract, and the consequences with the strongest evidence base: anti-nausea action (pregnancy, chemotherapy, post-operative, motion), acceleration of gastric emptying and effect on functional dyspepsia, reduction of inflammatory markers and musculoskeletal/exercise-related pain, modest improvements in fasting glucose and HbA1c in type-2 diabetes, and reduction of primary dysmenorrhoea pain. Out of scope: oncological chemopreventive claims (preclinical only) and cardiovascular hard endpoints (cohort data too thin).
Evidence by addressing question
mechanism
The anti-emetic effect runs through multiple receptors. 6-gingerol and 6-shogaol are 5-HT3 receptor antagonists in the enteric nervous system — the same receptor class targeted by ondansetron — and also act at muscarinic M3 and substance-P/NK1 sites, blocking the afferent vagal traffic that triggers vomiting Marx et al. 2013, Mashhadi et al. 2013. Peripherally, ginger stimulates antral contractions and accelerates gastric emptying: in a crossover trial of 24 healthy volunteers, 1.2 g of ginger powder reduced gastric emptying half-time from 16.1 to 12.3 min and produced antral motor activity within ~30 min of ingestion Wu et al. 2008. This dual mechanism — central anti-emetic plus pro-kinetic — explains why ginger calms nausea without delaying gastric clearance the way some 5-HT3 antagonists do.
The anti-inflammatory and analgesic effects derive from inhibition of arachidonic-acid metabolism. Gingerols and shogaols inhibit both COX-2 and 5-LOX, suppressing prostaglandin E2 and leukotriene B4, and downregulate NF-κB signalling, with downstream reductions in TNF-α, IL-1β, and IL-6 in vitro and in small human RCTs Mashhadi et al. 2013, Mozaffari-Khosravi et al. 2014. This is also the mechanistic basis for the dysmenorrhoea effect — menstrual pain is largely prostaglandin-mediated. 6-shogaol additionally activates TRPV1, producing the warmth and mild analgesia recognisable from a strong ginger tea.
Glucose effects are less mechanistically nailed down. Candidate pathways include inhibition of intestinal α-glucosidase and α-amylase (slowing carbohydrate absorption), AMPK activation in muscle and hepatocytes, and improved insulin sensitivity downstream of reduced low-grade inflammation Anh et al. 2020. Effect sizes are modest; the mechanism is multifactorial rather than dominant on any single pathway.
evidence
Across 109 RCTs reviewed in 2020, ginger has its strongest, most replicated evidence in nausea/vomiting and the most consistent biomarker movement in glycaemic and inflammatory endpoints; signals on other organ systems are weaker or preliminary Anh et al. 2020.
Nausea — pregnancy. The 2014 meta-analysis of 12 RCTs (n = 1278) found that 1.0–1.5 g/day ginger over 3–21 days significantly improved nausea symptoms versus placebo and was non-inferior to vitamin B6; no increase in spontaneous abortion, stillbirth, or congenital anomaly was observed Viljoen et al. 2014. ACOG's practice bulletin lists ginger as a first-line non-pharmacological option for nausea and vomiting of pregnancy.
Nausea — chemotherapy. A URCC CCOP four-arm RCT of 576 patients receiving moderately or highly emetogenic chemotherapy added ginger 0.5 g, 1.0 g, or 1.5 g daily (starting 3 days before chemo) or placebo to a standard 5-HT3 antagonist regimen. All three ginger doses significantly reduced acute (day-1) chemotherapy-induced nausea severity; the 0.5–1.0 g doses outperformed 1.5 g Ryan et al. 2012. The 2013 systematic review of seven RCTs concluded that ginger is a promising adjunctive antiemetic, with effect mostly on acute (not delayed) emesis and best results when started before chemotherapy Marx et al. 2013.
Nausea — post-operative. The 2006 meta-analysis pooled five RCTs (n = 363) and found that 1 g of ginger taken pre-operatively reduced 24 h post-operative nausea (RR 0.69, 95% CI 0.54–0.89) and vomiting (RR 0.61, 95% CI 0.45–0.84) versus placebo Chaiyakunapruk et al. 2006. Effect size comparable to a single 4 mg dose of ondansetron in those trials.
Nausea — motion sickness. In a circular-vection model of motion sickness (n = 13 healthy adults), 1 g of powdered ginger reduced both subjective nausea symptoms and the gastric tachyarrhythmias (3–9 cpm slow-wave dysrhythmias) that mark motion-sickness onset Lien et al. 2003. This is the smallest of the nausea trials and animal data is mixed, but the consistent finding across controlled provocations is real.
Gastric motility / functional dyspepsia. In addition to Wu et al. 2008's acceleration of gastric emptying in healthy volunteers, a crossover trial in functional-dyspepsia patients (n = 11) found that 1.2 g of ginger reduced gastric emptying half-time from 12.6 to 7.5 min, though this did not translate to symptom improvement over the short observation window Hu et al. 2011. The pro-kinetic effect is real and consistent; the symptom benefit in chronic functional dyspepsia is less established.
Inflammation + pain. The 2015 meta-analysis of five RCTs in knee osteoarthritis (n = 593) found that ginger 0.5–1 g/day for 3–12 weeks produced a statistically significant but modest reduction in pain (SMD −0.30, 95% CI −0.50 to −0.09) and disability (SMD −0.22) versus placebo, with mild GI side effects more common in the ginger arms (RR 2.33) Bartels et al. 2015. The authors classified evidence quality as "modest" — fewer than half of trials were low risk of bias. Black et al.'s 11-day eccentric-exercise RCT (n = 74) found that 2 g/day of raw or heated ginger reduced delayed-onset muscle soreness by ~25% at 24 h post-exercise Black et al. 2010. Inflammatory cytokines (TNF-α, IL-1β, hs-CRP) move modestly downward in small RCTs of older adults and patients with chronic disease Mozaffari-Khosravi et al. 2014.
Blood glucose. In a 12-week double-blind RCT (n = 70, type-2 diabetes), 2 g/day of ginger powder reduced fasting blood glucose by ~11%, HbA1c by ~0.5 percentage points (from 8.2 to 7.7), and ApoB/ApoA-I ratio compared with placebo Khandouzi et al. 2015. Meta-analyses of ~8–10 trials in T2D consistently find fasting glucose reductions of 0.4–1.1 mmol/L and HbA1c reductions of ~0.3–0.5 percentage points — clinically modest but real Anh et al. 2020. No meaningful effect demonstrated in non-diabetic populations.
Menstrual pain (dysmenorrhoea). The 2015 meta-analysis of six RCTs (n ≈ 500) found that 750 mg–2 g/day of ginger powder during the first 3–4 days of menses significantly reduced dysmenorrhoea pain versus placebo (effect size moderate-to-large; SMD ranging −1.3 to −0.8 across trials) Daily et al. 2015. Head-to-head trials show ginger 250 mg four times daily is non-inferior to mefenamic acid 250 mg and ibuprofen 400 mg for dysmenorrhoea pain relief Ozgoli et al. 2009. Evidence is among the strongest for any non-pharmacological dysmenorrhoea intervention.
protocol
Across the RCT literature, effective daily doses cluster at 0.5–2 g of powdered dried rhizome, equivalent to roughly 5–10 g of fresh root or ~4 cups of strong ginger tea (a thumb-sized piece of fresh ginger weighs ~10 g, of which ~5% is dry weight). For the highest-evidence indications: 1 g pre-operatively for PONV Chaiyakunapruk et al. 2006; 0.5–1 g/day starting 3 days before chemotherapy for CINV Ryan et al. 2012; 1–1.5 g/day in divided doses for pregnancy nausea Viljoen et al. 2014; 750 mg–2 g/day during the first 3–4 days of menstruation for dysmenorrhoea Daily et al. 2015; 2 g/day chronically for inflammatory and glycaemic effects Khandouzi et al. 2015. Onset for anti-emetic effect is ~30–60 min; plasma half-life of gingerols is ~2 h, so dividing into two or three doses extends coverage.
contraindications
Ginger has theoretical antiplatelet activity (inhibition of thromboxane synthesis), and a handful of case reports describe potentiation of warfarin's INR with high-dose ginger supplementation. RCTs at culinary and 2 g/day doses have not shown clinically significant effects on platelet aggregation, INR, or bleeding in healthy adults or in stable warfarin patients, but the safety signal is too small to confidently exclude an interaction at higher extract doses. Practical caution: anyone on warfarin, DOACs, or chronic aspirin should keep ginger to culinary amounts or coordinate higher doses with their prescriber Anh et al. 2020. High doses can cause heartburn or worsen reflux. Pregnancy data through 1.5 g/day is reassuring on miscarriage and congenital anomaly endpoints across 12 RCTs Viljoen et al. 2014; ACOG endorses use during pregnancy for nausea.
misconceptions
Three common misreads: (1) "Ginger settles the stomach by slowing things down" — the opposite, gastric emptying is accelerated, which is part of why it works for delayed-gastric-emptying nausea but can worsen reflux Wu et al. 2008. (2) "Anti-inflammatory like ibuprofen" — directionally yes (COX-2 inhibition), but effect size in OA is roughly a quarter to a third of NSAIDs; ginger is an adjunct, not a replacement, for inflammatory pain Bartels et al. 2015. (3) "Lowers blood sugar in everyone" — meaningful glucose effect is confined to type-2 diabetes and impaired fasting glucose; in healthy euglycaemic adults, ginger does not move fasting glucose or HbA1c Anh et al. 2020.
alternatives
For pregnancy nausea: vitamin B6 (pyridoxine) is comparable in evidence and routinely combined with doxylamine in the US/Canada (Diclegis/Diclectin); ginger and B6 show similar effect sizes and are often tried sequentially. For CINV: 5-HT3 antagonists (ondansetron) remain first-line and far more potent for highly emetogenic regimens; ginger is adjunctive. For PONV: ondansetron, dexamethasone, and acupressure at PC6 (P6/Neiguan) all have RCT evidence; ginger is one option among several with comparable effect sizes for moderate-emetic-risk surgery Chaiyakunapruk et al. 2006. For dysmenorrhoea: NSAIDs (ibuprofen, mefenamic acid, naproxen) are first-line; ginger is non-inferior in head-to-head trials but with slower onset and slightly weaker peak effect Ozgoli et al. 2009. For OA pain: exercise (the highest-evidence intervention by far), weight loss, topical NSAIDs, paracetamol, oral NSAIDs; ginger sits below all of these in effect size.
failure-modes
The two recurring reasons ginger underperforms in real life: dose is too low (a slice in stir-fry or one ginger tea bag delivers ~100–300 mg of dried-equivalent gingerols, well below the 1–2 g daily total used in trials) and form is wrong for the indication (raw juice or fresh root for chronic glucose/inflammation effects, where the trials almost all used standardized powdered extract; the gingerol-to-shogaol ratio differs and dosing is hard to estimate from food). For acute nausea, fresh or candied ginger works; for chronic indications, a measured supplement is more reliable.
practicalities
Fresh ginger root is sold per pound in essentially every grocery store globally and is among the cheapest spice-shelf interventions in the catalogue; a year of culinary use is typically under $30. Powdered standardized extract (4–5% gingerols) is widely available, ~$15–25/month for 1–2 g/day. No prescription, no clinician visit, no monitoring. Storage: fresh root keeps ~3 weeks in the fridge or ~6 months frozen.
The credibility range
Optimist case
Ginger is the rare botanical with both a coherent multi-receptor mechanism (5-HT3, COX-2, NF-κB, TRPV1) and a deep RCT base — 109 trials reviewed in 2020 Anh et al. 2020. It is non-inferior to ondansetron 4 mg for PONV at a single 1 g dose Chaiyakunapruk et al. 2006; non-inferior to ibuprofen 400 mg for primary dysmenorrhoea Ozgoli et al. 2009; the only oral antiemetic with safety data in pregnancy supporting routine use Viljoen et al. 2014; and reduces HbA1c by ~0.5 percentage points in T2D, on par with some pharmaceutical add-ons Khandouzi et al. 2015. Cost, side-effect profile, and accessibility are unmatched. The case for keeping it in the house is overwhelming.
Skeptic case
Most ginger trials are small (n < 100), short (4–12 weeks), and conducted in single centres in Iran, Thailand, and Australia rather than as large multi-centre Western trials; publication bias is plausible and the OA meta-analysis explicitly flagged it Bartels et al. 2015. Effect sizes outside nausea are modest: SMD −0.30 in OA pain (clinical-significance threshold is typically −0.4 to −0.5); fasting glucose drops of ~10% in T2D are real but unlikely to change clinical decisions; the inflammation-marker movements are downstream surrogates, not hard endpoints. Standardization across products is poor — gingerol content varies 3-fold between commercial powders. And the central-pharmacology cleanness is overstated: ginger does not match ondansetron for highly emetogenic chemo. Skeptic call: useful for self-limited nausea and as a low-cost adjunct, oversold for chronic disease.
Author's call
Lean optimist on the nausea cluster (pregnancy, CINV adjunctive, PONV, motion) and on dysmenorrhoea — the evidence is mature, multi-trial, and consistent. Lean cautious on chronic indications (OA, T2D, inflammation): effects are real but modest, and the smart positioning is "low-cost adjunct on top of first-line treatment", not "alternative to the first-line treatment". Evidence overall is a 3 — strong on one cluster, modest-and-mixed on another, with mechanism credible across both. Controversy is low (1) — the field broadly agrees on what ginger does and where the evidence ends.
Stakeholder + incentive map
- Supplement industry markets standardized ginger extract for nausea, OA, glucose, and "general inflammation" — financial incentive to oversell chronic-disease claims where the data is weakest.
- Obstetrics (ACOG, RCOG) endorses ginger as first-line non-pharmacological for nausea and vomiting of pregnancy — guidelines aligned with the evidence.
- Oncology supportive care (NCCN, MASCC) lists ginger as an option for CINV but not a primary recommendation — appropriate hedging given adjunctive nature.
- Traditional medicine systems (Ayurveda, TCM) have used ginger for ~2000 years for nausea, digestion, and "cold" conditions — historical practice that anticipated the modern mechanism.
- Pharma has limited incentive to study a cheap unpatentable rhizome; this is part of why high-quality multi-centre trials are scarce.
Population variability
- Pregnant women — best-evidenced population for the anti-nausea effect; safety profile robust through 1.5 g/day Viljoen et al. 2014.
- Chemotherapy patients — effect demonstrated in mixed-cancer cohorts on moderate-to-high emetogenic regimens, started before chemo; less helpful if started after symptoms begin Ryan et al. 2012.
- Women with primary dysmenorrhoea — robust effect; secondary dysmenorrhoea (endometriosis, fibroids) is less studied and likely needs different treatment.
- Type-2 diabetics — glycaemic effects clearest here; not seen in healthy controls Anh et al. 2020.
- Adults on warfarin/DOACs/aspirin — theoretical interaction; culinary doses safe, supplemental doses warrant clinician coordination.
- Reflux/GERD sufferers — the pro-kinetic effect can be either helpful (gastroparetic phenotype) or worsen symptoms (reflux phenotype); individual response varies.
- Children — most trials in adults; ginger is used in paediatric anti-emetic protocols anecdotally but evidence is thin.
Knowledge gaps
Open questions: (1) cardiovascular hard endpoints — does the modest reduction in lipids, glucose, and inflammatory markers translate to MACE reduction? No long-term outcomes trial exists. (2) Optimal form and standardization — fresh vs powder vs standardized extract, gingerol-to-shogaol ratio, with-food vs fasted. (3) Comparative effectiveness against 5-HT3 antagonists for highly emetogenic chemotherapy at higher ginger doses (3+ g) has not been tested. (4) Bleeding/anticoagulant interaction at supplemental doses — current safety signal rests on small trials and case reports, not on adequately powered pharmacokinetic studies. (5) Whether the gastric pro-kinetic effect translates to chronic functional-dyspepsia symptom relief over months has not been studied with the right trial design. Evidence that would change the author's call: a large multi-centre trial showing meaningful glycaemic effect in pre-diabetic adults (would raise the longevity score), or a pharmacokinetic interaction study confirming clinically significant anticoagulant potentiation at 2 g/day (would raise controversy and tighten contraindications).
Scope vs. brief. The brief named nausea, postprandial gastric motility, inflammatory and pain markers, blood glucose, and menstrual pain. The article covers all five end-to-end. The gastric-motility material is folded into the mechanism + misconceptions sections rather than getting its own addressing section because the felt-experience hook for the average reader is nausea relief, not motility per se; the motility data is the why, not the standalone what. Editor reviewing should check this call.
What was deliberately excluded.
- Preclinical chemopreventive claims (anti-cancer activity in cell lines and rodents) — meaningful preclinical signal but no human outcomes trials; including would have inflated the longevity score on the strength of bench data, which the catalogue's evidence bar doesn't allow.
- Cardiovascular hard endpoints. Biomarker movements (lipids, glucose, CRP) are real; no long-term MACE or mortality trial exists. Reflected by capping longevity at 1.
- Cognitive / Alzheimer's claims. Animal-model anti-neuroinflammatory data only; no human trials worth citing. Excluded entirely rather than wedged into
focusormood. - Ginger's role in TCM and Ayurveda — touched briefly in the stakeholder map of the research dossier but kept out of the article because the entry is reader-action focused, not historical.
Hard scoring calls.
health_short_term: 3— could plausibly be a 4 for the people in the specific use-cases (pregnancy, chemo, dysmenorrhoea), where the felt-experience effect is substantial. Landed at 3 because the holistic score has to average across all readers and most won't be in those use-cases on any given day. The pitch leads with the strongest use-cases to do that work instead.evidence: 3rather than 4 — anchored to the chronic-disease cluster, where trials are small and single-centre. The nausea + dysmenorrhoea cluster alone would justify a 4; averaged across the whole substance, 3 is the honest call.controversy: 1rather than 0 — minor pushback exists on whether the OA pain effect crosses the clinical-significance threshold (SMD -0.30 sits below the usual -0.40 to -0.50 line), and on the warfarin interaction signal. Not enough to warrant 2.cadence: as-neededrather thandaily— the highest-leverage uses are episodic (surgery, chemo, period, motion). Daily ginger is fine but mostly low-impact for healthy adults. "As-needed" matches the action the reader is most likely to take after reading.
Contraindication call. Listed blood-thinners. Did not list pregnancy because the dossier's safety signal through 1.5 g/day is reassuring and ACOG endorses it; flagging pregnancy as a contraindication would block the most-evidenced use.
Dream-narrative call. Overall score ~23, below the 40 obligatory line. Wrote a brief relief-lever narrative anyway because the honest hook ("the antiemetic was in the kitchen the whole time") supports it; the dek and tagline both crank from it.
Future links to wire when they exist.
vitamin-b6(alternative pregnancy antiemetic)pc6-acupressure(alternative motion + post-op antiemetic)peppermint-oil(IBS / cramping adjacent)ibuprofenor a broader NSAIDs entry (dysmenorrhoea + OA alternative)knee-osteoarthritis-exercise(the dominant lever ginger sits underneath)
Separate-entry candidates surfaced during the write. None worth flagging; the substance is unified enough that one entry covers it cleanly.
Ginger
Fresh root sells per pound globally; a year of culinary use is under $30. Standardized 1-2 g/day extract is $15-25/month. No prescription, no monitoring, no clinician visit.
Either keep a root in the fridge and grate it in, or take a capsule. No dietary restructuring, no protocol, no willpower load.
Multiple meta-analyses converge on a clear felt-experience effect: ginger 1 g pre-op reduces 24h PONV (RR 0.69) [Chaiyakunapruk2006]; 1-1.5 g/day reduces pregnancy nausea [Viljoen2014]; 0.5-1 g/day reduces acute CINV in a 576-patient RCT [Ryan2012]; 750 mg-2 g/day cuts dysmenorrhoea pain non-inferior to ibuprofen 400 mg [Daily2015, Ozgoli2009]. Effects land within 30-60 min for acute use.
109 RCTs reviewed in [Anh2020]. Strongest cluster: nausea (pregnancy, CINV adjunctive, PONV) and dysmenorrhoea, with multi-trial meta-analyses [Viljoen2014, Marx2013, Chaiyakunapruk2006, Daily2015]. Modest cluster: OA pain (SMD -0.30 [Bartels2015]), glycaemia in T2D, inflammatory markers. Not 4 because outside nausea/dysmenorrhoea, trials are small, single-centre, and modest effect size; not 2 because the mechanism is well-characterised across 5-HT3, COX-2, and TRPV1 pathways.
Modest contribution via the inflammation and glycaemia pathways — 2 g/day reduces HbA1c by ~0.5 pp and fasting glucose by ~10% in T2D [Khandouzi2015, Anh2020] and trims TNF-alpha and hs-CRP modestly [Mozaffari-Khosravi2014]. No long-term mortality or MACE trial exists; biomarker movements are real but the chain to hard endpoints is unproven.